i10 Productivity
Rankings
AstraZeneca, Sweden Scientists i10 Productivity Rankings (Sort by last 6 years i10 Index) 2024
Productivity Rankings is a unique service offered only by “AD Scientific Index”. This is a ranking system derived from the i10 index in order to show the productivity of the scientist in publishing scientific articles of value. Productivity Rankings is an instrument that lists productive scientists in a given area, discipline, university, and country and can guide the development of meaningful incentives and academic policies. The world rankings, regional rankings, and university rankings of scientists in this table are developed based on the total i10 index. Click for "last 6 years' i10 index". Also see: Universities Rankings 2024 (Sort by : Total i10 Index) and Universities Rankings 2024 (Sort by : Last 6 Years i10 Index)
Data Science
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
163
136
0.834
transporters
drug metabolism
pharmacokinetics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
286
131
0.458
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
244
129
0.529
Oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
143
129
0.902
Cheminformatics
Drug Discovery
Machine Learning
Semantic Web Technologies
Open Innovation
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
135
108
0.800
Clinical Trials
Longitudinal Data
Evidence Synthesis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
109
99
0.908
Homogeneous catalysis
reaction mechanisms
molecular modeling
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
190
91
0.479
meta-analysis
missing data
statistics
biostatistics
miscellaneous statistical theory
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
95
83
0.874
Proteomics
Cell Biology
Bioanalytical Chemistry
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
122
82
0.672
Physiology
Metabolism
Transgenic
CRISPR
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
104
82
0.788
Developing inhibitors of the DNA Damage Response into new medicines for cancer patients
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
94
79
0.840
Immunotherapy
microbiome
and targeted therapy for oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
85
79
0.929
Clinical Pharmacology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
119
78
0.655
Drug metabolism and disposition
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
177
77
0.435
bioinformatics
drug discovery
AI/ML
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
78
77
0.987
CAR-T
Treg
iPSC
genome editing
lentiviral and AAV vectors
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
133
74
0.556
statistics
clinical trials
regulatory submission for drug development
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
138
73
0.529
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
103
72
0.699
replicability
reproduciblity
in-vivo
experimental design
sex bias
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
78
67
0.859
MS imaging
molecular imaging
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
70
66
0.943
drug discovery and development
viruses and epithelial biology
non coding RNA
post translational modification
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
99
63
0.636
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
71
63
0.887
molecular pharmacology
oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
83
62
0.747
Early Phase Oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
80
62
0.775
From directed protein evolution to experimental medicine
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
76
62
0.816
Noel Southall
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
163
136
0.834
Anshul Gupta
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
286
131
0.458
transporters
drug metabolism
pharmacokinetics
Outi Vaarala
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
244
129
0.529
Maurizio Scaltriti
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
143
129
0.902
Ola Engkvist
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
135
108
0.800
Cheminformatics
Drug Discovery
Machine Learning
Semantic Web Technologies
Open Innovation
Michael Sweeting
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
109
99
0.908
Per-Ola Norrby
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
190
91
0.479
Homogeneous catalysis
reaction mechanisms
molecular modeling
Dan Jackson
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
95
83
0.874
meta-analysis
missing data
statistics
biostatistics
miscellaneous statistical theory
Sonja Hess
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
122
82
0.672
Proteomics
Cell Biology
Bioanalytical Chemistry
Mohammad Bohlooly-Y
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
104
82
0.788
Physiology
Metabolism
Transgenic
CRISPR
Mark J O'Connor
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
94
79
0.840
Developing inhibitors of the DNA Damage Response into new medicines for cancer patients
Zachary A Cooper
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
85
79
0.929
Immunotherapy
microbiome
and targeted therapy for oncology
David Boulton
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
119
78
0.655
Tommy B Andersson
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
177
77
0.435
Dimitris Polychronopoulos
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
78
77
0.987
bioinformatics
drug discovery
AI/ML
Yasuhiro İkeda
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
133
74
0.556
CAR-T
Treg
iPSC
genome editing
lentiviral and AAV vectors
Jenny Han
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
138
73
0.529
statistics
clinical trials
regulatory submission for drug development
Mark Birrell
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
103
72
0.699
Natasha Karp
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
78
67
0.859
replicability
reproduciblity
in-vivo
experimental design
sex bias
Richard Ja Goodwin
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
70
66
0.943
Rose A Maciewicz
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
99
63
0.636
drug discovery and development
viruses and epithelial biology
non coding RNA
post translational modification
Bret Sellman
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
71
63
0.887
Sylvie Guichard
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
83
62
0.747
molecular pharmacology
oncology
Emma Dean
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
80
62
0.775
Lutz Jermutus
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
76
62
0.816
From directed protein evolution to experimental medicine